Related Experiment Video

Updated: May 9, 2025

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
03:42

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models

Published on: September 27, 2024

1.2K

FABP4-tastic Pancreatic Stellate Cells Coddle KITL to Uphold Inherent Microenvironmental Tumor Suppression

Aleksandr Dolskii1, Edna Cukierman1

  • 1Cancer Signaling & Microenvironment Program, Marvin and Concetta Greenberg Pancreatic Cancer Institute, Fox Chase Cancer Center, Lewis Katz School of Medicine, Temple Health, Philadelphia, Pennsylvania.

Cancer Discovery
|April 30, 2025
PubMed

Insights

Loss of KIT ligand (KITL) in pancreatic stellate cells drives pancreatic cancer by weakening the tumor-suppressive microenvironment. Restoring KITL may offer a new therapy to reactivate natural anti-tumor defenses.

Area of Science:

  • Oncology
  • Cancer Biology
  • Microenvironment Research

Background:

  • The pancreatic microenvironment plays a critical role in cancer development.
  • Tumor suppression by the natural microenvironment is a long-standing hypothesis.
  • Pancreatic stellate cells are key components of the pancreatic microenvironment.

Purpose of the Study:

  • To investigate the role of KIT ligand (KITL) expression in pancreatic stellate cells.
  • To determine the impact of KITL loss on pancreatic cancer development.
  • To explore therapeutic strategies targeting the pancreatic tumor microenvironment.

Main Methods:

  • Analysis of KITL expression in pancreatic stellate cells.
  • Investigating the functional consequences of KITL loss in the pancreatic microenvironment.
  • Assessing the potential for restoring KITL expression as a therapeutic approach.

Main Results:

  • KITL expression in pancreatic stellate cells is essential for tumor suppression.
  • Loss of KITL enables pancreatic cancer development.
  • Restoring KITL can reestablish tumor-suppressive functions in pancreatic fibroblasts.

Conclusions:

  • KITL in pancreatic stellate cells is a critical tumor suppressor.
  • Targeting KITL offers a potential therapeutic strategy for pancreatic cancer by restoring microenvironmental defenses.

More Related Videos

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth06:35

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

4.3K
Isolating and Analyzing Cells of the Pancreas Mesenchyme by Flow Cytometry05:38

Isolating and Analyzing Cells of the Pancreas Mesenchyme by Flow Cytometry

Published on: January 28, 2017

12.1K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.4K